abstract |
"NET PHARMACEUTICAL COMPOSITION". The present invention relates to a liquid pharmaceutical composition of a GABA analog comprising at least one polyhydric alcohol containing from 2 to 6 carbon atoms having a pH of about 5.5 to 7.0 and additionally a pharmaceutical composition. a two-component liquid composition comprising a first component comprising a powder mixture comprising a GABA analog and a solid polyhydric alcohol and a second component comprising a liquid base as well as methods of preparing the compositions and a method of treating brain diseases. including epilepsy, fainting attacks, hypokinesia, and head injuries, neurodegenerative disorders, depression, mania and bipolar disorders, anxiety, panic, inflammation, renal colic, insomnia, gastrointestinal damage, incontinence, pain, including neuropathic pain, muscle pain, pain and migraine using a therapeutically effective amount of the compositions pharmaceuticals. |